In this episode, we discuss the hot topic of wastewater epidemiology and the heightened role it plays in our world today. Keith Hays, Vice President of Bluefield Research, discusses his latest research on pinpoint detection of pathogens and contagions in wastewater and the potential economic & healthcare benefits it could bring to society.
Key questions addressed:
In this episode, Bluefield’s Keith Hays and Eric Bindler, delves into the canned-water company Liquid Death and the growing questions about bottled water, the...
On 24 January 2023, US-based Xylem Inc. and Evoqua announced an agreement in which Xylem will acquire Evoqua in an all-stock transaction for an...
The Bluefield team discusses their take on private participation in water, breaking down the where and who is leading the way. The discussion builds...